HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease.
By K. Karell, A. S. Louka, S. Moodie, H. Ascher, F. Clot, L. Greco, P. Ciclitira, Ludvig M. Sollid, J. Partanen. Human Immunology, 2003
631 citations recorded by the source corpus.
Subfields: Epidemiology, Gastroenterology, Surgery
View Paper: https://www.semanticscholar.org/paper/fd1ee2e694d81c1b8705cb904aebc964c774937d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- D. Leffler
- J. Bai
- J. Ludvigsson
- F. Biagi
- T. Card
- D. Sanders
- P. Green
- K. Lundin
Citations in the corpus
- Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology (2014, background): “…its high negative predictive value, meaning that patients who lack the appropriate HLA genotype pairs described above are very unlikely to have CD. 90 However, the positive predictive value of the HLA genotyping for CD susceptibility is very low as a large proportion of individuals without CD…”
- Multiple common variants for celiac disease influencing immune gene expression (2010, neutral): “8 × 10 −8 ), which is consistent with the well-described North-South gradient in HLA allele frequency in European populations, and more specifically for HLA-DQ in celiac diseas”
- European Society for Pediatric Gastroenterology, Hepatology, and Nutrition Guidelines for the Diagnosis of Coeliac Disease (2012, neutral): “5 100 Fernandez-Arquero, 1995 (126) NIH; c-c Spain Known CD 100 92 Ferrante, 1992 (127) NIH; c-c Italy Known CD 50 88 Fine, 2000 (128) NIH; c-c USA Known CD 25 88 Howell, 1995 (129) NIH; c-c England Known CD 91 91 Iltanen, 1999 (130,131) NIH; c-c Finland Known CD 21 90 Johnson, 2004 (132) c-c New Yo”